Jill R. Harper | |
---|---|
Born | 1972 (age 50–51) |
Alma mater | Oglethorpe University Princeton University |
Scientific career | |
Fields | Molecular biology |
Institutions | National Institute of Allergy and Infectious Diseases |
Thesis | The role of periplasmic protein folding factors in escherichia coli (2001) |
Doctoral advisor | Thomas J. Silhavy |
Jill Reiss Harper (born 1972) [1] is an American molecular biologist and policy advisor serving as the deputy director for science management and executive officer at the National Institute of Allergy and Infectious Diseases.
Harper earned a B.S. in biology with a minor in chemistry from Oglethorpe University in 1994. She was on the volleyball team for 4 years. [2] She completed a M.A. and a Ph.D. in molecular biology from Princeton University. Her 2001 dissertation was titled The role of periplasmic protein folding factors in escherichia coli. Thomas J. Silhavy was Harper's doctoral advisor. [3] She was an American Society for Microbiology congressional science fellow. As a fellow starting in September 2001, Harper spent a year as a legislative assistant in a U.S. Representative’s office, where she worked on issues related to science and technology and bioterrorism. [4]
Harper joined National Institute of Allergy and Infectious Diseases (NIAID) in 2002. She served as the chief of the legislative affairs and correspondence management branch, in the NIAID office of communications and government relations, where she led congressional liaison and legislative analysis activities for NIAID. Harper was later the director of the NIAID office of biodefense research and surety (OBRS), where she led the National Institutes of Health (NIH) chemical countermeasures research program and coordinated surety functions, including emergency preparedness, physical and personnel security, and biosurety, across the institute. Harper served as the associate director for science management at NIAID. She is now the NIAID deputy director for science management. In this position, Harper provides leadership for scientific, policy, business, and administrative management of the Institute and conducts senior-level interactions with the extramural community, other NIH components, and the NIH Office of the Director. She also serves as the executive officer of NIAID. [4]
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.
A bacteriologist is a microbiologist, or similarly trained professional, in bacteriology -- a subdivision of microbiology that studies bacteria, typically pathogenic ones. Bacteriologists are interested in studying and learning about bacteria, as well as using their skills in clinical settings. This includes investigating properties of bacteria such as morphology, ecology, genetics and biochemistry, phylogenetics, genomics and many other areas related to bacteria like disease diagnostic testing. Alongside human and animal healthcare providers, they may carry out various functions as medical scientists, veterinary scientists, or diagnostic technicians in locations like clinics, blood banks, hospitals, laboratories and animal hospitals. Bacteriologists working in public health or biomedical research help develop vaccines for public use.
Kathryn C. Zoon is a U.S.-based immunologist, elected to the U.S. Institute of Medicine in 2002 for her research on human interferons. She is the former scientific director of the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) in Bethesda, Maryland. From 1992 to 2002, Zoon was director of the FDA Center for Biologics Evaluation and Research (CBER).
Julie E. Ledgerwood is an American allergist and immunologist, who is the chief medical officer and serves as chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in Bethesda, Maryland. She is a Doctor of Osteopathic Medicine.
Richard Michael Krause was an American physician, microbiologist, and immunologist. He was the director of the National Institute of Allergy and Infectious Diseases from 1975 to 1984. Krause later served as the dean of medicine at Emory University before returning to National Institutes of Health as a senior scientific advisor at the John E. Fogarty International Center. Krause was formerly a longtime professor at Rockefeller University.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Kim Yarbrough Green is an American virologist. She is chief of the caliciviruses section in the laboratory of infectious diseases at the National Institute of Allergy and Infectious Diseases. She researches noroviruses in human disease, disease prevention, and control strategies.
Patrizia Farci is an Italian scientist and hepatologist. She is chief of the hepatic pathogenesis section at the National Institute of Allergy and Infectious Diseases. Farci conducts translational research in the field of liver diseases, particularly in the study of pathogenesis of acute and chronic viral hepatitis. She was previously a full professor of medicine and director of the liver unit and the postgraduate school of gastroenterology at the University of Cagliari.
Lori Elizabeth Dodd is an American mathematical statistician specializing in clinical trials methodology, statistical analysis of genomic data, design of clinical trials using biomarkers and imaging modalities, and statistical methods for analyzing biomarkers. She is a statistician in the biostatistics research branch at the National Institute of Allergy and Infectious Diseases.
Terri Grodzicker is an American molecular geneticist and virologist who is currently the Dean of Academic Affairs at Cold Spring Harbor Laboratory. She also serves as the editor-in-chief of Genes & Development. Her research is in the field of human Adenoviridae. During her career at Cold Spring Harbor Laboratory she has edited more than a dozen books, and co-authored papers and books with other renown members of the laboratory such as Joseph Sambrook and Bruce Stillman.
Dr. Michael J. Lenardo, is the chief of the Molecular Development and Immune System Section and the founder and co-Director of the Clinical Genomics Program at the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH). Trained as a geneticist, molecular biologist, and immunologist, his research examines how cells of the immune system defend themselves against various pathogens, including viruses and bacteria. His research has investigated genetic abnormalities in the immune system, mechanisms of cell death, genetic diseases of immune homeostasis and autoimmunity, and development of novel diagnostics and therapeutics for diseases of the immune system. Lenardo's contributions to science and medicine have shown the possibilities of genomic research in developing precision medicine diagnoses and treatments for disease in humans. In 2006 he was appointed Officer of the Most Excellent Order of the British Empire (O.B.E.) by Queen Elizabeth II. In 2019 he was inducted into the National Academies of Sciences and the National Academy of Medicine, considered among the highest honors awarded to a U.S scientist and medical researcher respectively.
Adah Elizabeth Verder was an American medical bacteriologist and science administrator. She was a researcher in the National Institute of Allergy and Infectious Diseases' (NIAID) intramural research program specialized in gastrointestinal flora and staphylococci, pseudomonas, and pleuropneumonia organisms. Verder later served as chief of the bacteriology and mycology branch in the extramural division of NIAID. She was a fellow of several societies including the American Association for the Advancement of Science, American Public Health Association, American Academy of Microbiology, and the New York Academy of Sciences.
Hugh Auchincloss, Jr., is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022. He was previously a transplant surgeon and professor of surgery at Harvard Medical School, and researched at Massachusetts General Hospital for 17 years.
Tara N. Palmore is an American physician-scientist and epidemiologist specializing in patient safety through prevention of hospital-acquired infections. As of 2021 she was the hospital epidemiologist at George Washington University School of Medicine and Health Sciences.
John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.
Tara A. Schwetz is an American biophysicist and government administrator who is currently serving as the Acting Principal Deputy Director of the National Institutes of Health (NIH).
Kanta Subbarao is an Indian virologist, molecular geneticist, and physician-scientist. She is director of the World Health Organization collaborating centre for reference and research on influenza. Subbarao is also a professor at the Doherty Institute.
Alice M. Laskey was a U.S. Naval Officer and biochemist and who worked in the National Institutes of Health division of research grants and the National Institute of Allergy and Infectious Diseases. She was a lieutenant commander during World War II.